Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Orgenesis Q3 EPS $(1.93) Down From $(0.12) YoY, Sales $347.00K Up From $110.00K YoY

Author: Benzinga Newsdesk | November 13, 2024 09:24am
Orgenesis (NASDAQ:ORGS) reported quarterly losses of $(1.93) per share. This is a 1508.33 percent decrease over losses of $(0.12) per share from the same period last year. The company reported $347.00 thousand in sales this quarter. This is a 215.45 percent increase over sales of $110.00 thousand the same period last year.

Posted In: ORGS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist